OncoSec Medical Presents New Data at 10th Annual PEGS: The Essential Protein Engineering Summit in Boston

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, today presented preliminary experimental findings demonstrating that electroporation with DNA-based IL-12 in mice can lead to systemic anti-tumor immune responses in distant untreated lesions.



from Content Keyword RSS http://ift.tt/1fJp2hY

via IFTTT